The Lundquist Institute

10/03/2025

To celebrate the incredible people behind TLI and spotlight our team, we’ve launched The Lundquist Institute Voices 💬 Through rapid fire questions, our team members share their unique stories, perspectives, and passions. Get ready to meet the voices that make TLI a special and innovative place 🚀

Meet Bridgette Blebu, PhD, a junior faculty TLI investigator and analyst at L.A. County Health Services. Her research includes addressing maternal health and perinatal care disparities by integrating implementation research in clinical settings to improve the uptake of evidence-based practices.

10/02/2025

To celebrate the incredible people behind TLI and spotlight our team, we’ve launched The Lundquist Institute Voices 💬 Through rapid fire questions, our team members share their unique stories, perspectives, and passions. Get ready to meet the voices that make TLI a special and innovative place 🚀

Meet Bridgette Blebu, PhD, a junior faculty TLI Investigator and Analyst at the LA County Department of Health Services (). Her research includes addressing maternal health and perinatal care disparities by integrating implementation research in clinical settings to improve the uptake of evidence-based practices.

Swipe left to learn more about Bridgette!

10/01/2025

A recent clinical study led by TLI Investigator Loren Miller, MD, MPH evaluated the use of dalbavancin as a potential treatment for complicated Staphylococcus aureus, commonly referred to as a “staph infection."

The study found that two doses of dalbavancin administered over 4–8 weeks demonstrated comparable outcomes to the current standard of care, which requires several weeks of intravenous antibiotics.

These findings underscore the need for continued research into dalbavancin as a simplified therapeutic option that may reduce the risks, burden, and costs associated with long-term IV therapy. Read the full article below.

TLI Investigator Loren Miller, MD, MPH and other researchers have reason to believe that novel antibiotic dalbavancin could be a viable alternative to treating Staphylococcus aureus or "staph infection."

09/30/2025

Due to unforeseen circumstances, we unfortunately had to cancel tomorrow's Science and Your Health. We are working to reschedule this event. New date to be announced - stay tuned!

You're invited to an insightful lecture on Wednesday, October 1 at 12pm PT by WIC South Los Angeles Executive Director Marisela Montoya, EdD titled “Early Life, Lifelong Impact: Lundquist WIC as a Partner for Translational Public Health.”

Dr. Montoya will explore how The Lundquist Women, Infants, and Children (WIC) Program‘s early-life interventions, culturally tailored education, and community trust can enhance translational research and expand the impact of clinical work.

Learn more about Dr. Montoya's work and gain insight into how research can intersect with community-based models of care, as well as how WIC's infrastructure can help bring science into action—where it matters most.

Register for the FREE community event today! bit.ly/3VojAYT.

09/25/2025

This World Lung Day, we’re spotlighting a major step forward in the fight for global lung health and reaffirm our commitment advancing science to reduce breathlessness and increase exercise capacity.

At TLI, our researchers are leading clinical trials for the next-gen cardiopulmonary exercise test — the mCPET (musculo-cardiopulmonary exercise test). This innovation goes beyond traditional CPET by integrating muscle function assessment during exercise, including characterizing reference ranges, responsiveness to interventions, and distinguishing between deconditioning and disease.

Our team at the Respiratory Research Center, led by Investigator Harry Rossiter, PhD is pioneering this method with the potential to transform how we evaluate respiratory conditions. 📽️ Watch our video to see how the mCPET clinical trials are reshaping diagnostic precision — and offering new hope to patients.

09/22/2025

We are proud to welcome TLI Investigator Paul Mathews, PhD to The Lundquist Institute’s Board of Directors!

A first-generation college student turned neuroscience leader, Dr. Mathews currently serves as Director of the Neurotherapeutics Institute and has spent more than a decade at The Lundquist Institute. "Joining the TLI Board is a privilege, and I hope to contribute a bench-side researcher’s perspective to its discussions and decisions,” said Dr. Mathews.

Whether advancing groundbreaking research on Ataxia-Telangiectasia or building structure and support for our graduate programs, Paul exemplifies the values at the core of our mission: scientific excellence, inclusive mentorship, and community leadership.

Read more about Paul Mathews, PhD: bit.ly/4nLsjk5

09/19/2025

What an incredible evening at Women In Bio–Los Angeles Leading in Los Angeles event! ✨

We heard powerful insights from powerhouse panelists from BioLabs at The Lundquist Institute, Huntington Medical Research Institutes-Pasadena, Los Angeles County Department of Economic Opportunity, and University Lab Partners. From fostering leadership and mentorship in biotech to creating more opportunities within LA’s life sciences ecosystem, all left inspired and energized about what’s ahead for women leaders in biotech, medtech, and beyond! 🚀

A huge thank you to our panelists, attendees, and everyone who made this night possible. Together, we’re shaping the next chapter of biotech in Los Angeles. 🌱💡

09/18/2025

You're invited to an insightful lecture on Wednesday, October 1 at 12pm PT by WIC South Los Angeles Executive Director Marisela Montoya, EdD titled “Early Life, Lifelong Impact: Lundquist WIC as a Partner for Translational Public Health.”

Dr. Montoya will explore how The Lundquist Women, Infants, and Children (WIC) Program‘s early-life interventions, culturally tailored education, and community trust can enhance translational research and expand the impact of clinical work.

Learn more about Dr. Montoya's work and gain insight into how research can intersect with community-based models of care, as well as how WIC's infrastructure can help bring science into action—where it matters most.

Register for the FREE community event today! bit.ly/3VojAYT.

09/17/2025

To celebrate the incredible people behind TLI and spotlight our team, we’ve launched The Lundquist Institute Voices 💬 Through rapid fire questions, our team members share their unique stories, perspectives, and passions. Get ready to meet the voices that make TLI a special and innovative place 🚀

Meet Sharon Moore, MS, RDN, LEC from The Lundquist Women, Infants and Children (WIC) Program. Sharon is currently serving as Deputy Chief of WIC South Los Angeles' Breastfeeding Services.

She has expanded her expertise to include lactation education counseling (LEC), guiding WIC staff on the crucial aspects of breastfeeding/chestfeeding. Sharon also spearheads Story Time initiatives within the agency.

09/17/2025

Los Angeles is booming — and you’re invited to the conversation shaping its future.🚀 Join us tomorrow, September 18 for Women In Bio-Los Angeles' Leading in Los Angeles event at The Lundquist Institute!

Meet the trailblazers driving innovation in SoCal’s life sciences sector and gain real-world insights on leadership, capital efficiency, and community-building in biotech.

This event will feature powerhouse panelists from BioLabs at The Lundquist Institute, Huntington Medical Research Institutes (HMRI), Los Angeles County Department of Economic Opportunity, and University Lab Partners, and will be moderated by TLI's Jennifer Strong.

Register today! https://lnkd.in/grFjEcww

09/15/2025

This week marks Fungal Disease Awareness Week to highlight the growing public health threat posed by fungal infections.🦠

Per the Centers for Disease Control and Prevention (CDC), many fungal diseases are an emerging global health threat — often under-recognized, frequently misdiagnosed, and increasingly resistant to available treatments. Timely detection and appropriate antifungal therapy can save lives, yet the need for innovation in diagnostics, therapeutics, and surveillance remains urgent.

At The Lundquist Institute, we are committed to advancing translational research that addresses these challenges — from studying the molecular mechanisms of fungal pathogens to developing novel tools for early detection and treatment. Our recent stories showcase that commitment and the impact of our science on public health. 🧬🔬

Join us in raising awareness: Early detection matters, proper treatment saves lives. Support our work and other critical research at TLI: lundquist.org/donate/.